Stockholder Alert - Robbins LLP Informs Investors of the SmartSheet Inc. Class Action

A securities class action was filed against Smartsheet (SMAR) over alleged federal securities-law violations tied to share repurchases while a consortium (Blackstone and Vista) proposed offers at a premium. The complaint alleges Smartsheet repurchased 1.128M shares for about $50M (June–August 2024) while not disclosing the consortium’s credible higher-price offers, despite later execution of a $56.50/share merger agreement after an initial $56.25/share approach. The stock reportedly rose sharply when investors learned of the premium offers, but the lawsuit adds legal/regulatory overhang for SMAR during the June 1, 2024–Sep 23, 2024 class period.

Analysis

This is mostly a governance and disclosure-risk issue, not a fundamental earnings event. The economic value transfer is backward-looking and likely to accrue over years through settlement economics, so the near-term P&L impact is limited unless discovery uncovers sponsor-level involvement or board minutes that broaden the defendant set.

For public markets, the main second-order effect is on how SaaS boards handle capital returns during strategic reviews. Expect a modest chill on buybacks when M&A conversations are plausible, which could reduce the share-price support premium investors assign to repurchase-heavy software names; that matters more for companies with weak organic growth and active capital-return messaging than for high-quality compounders.

The contrarian miss is that this likely gets overread as a Blackstone issue. For BX, the event is reputational noise unless regulators get involved; for the broader software complex, the signal is that buyback announcements are less credible when a company is already in play. Falsifiers: any SEC inquiry, amended complaint naming additional deep-pocket defendants, or a large headline settlement reserve would change the risk profile materially.

Time horizon matters: days = headline volatility only; 1-3 months = discovery and amended filings; 6-18 months = settlement/insurance recovery. Absent a new catalyst, there is little reason to expect a durable valuation impact on either BX or the sector.

Key Decisions for Investors

• Do not initiate a standalone SMAR trade; this is a closed-deal litigation overhang with no clean public-market expression and a multi-year payoff horizon.
• If BX sells off >1% on litigation headlines, fade the move with a short-dated call spread or a long BX / short IWM pair; the expected legal cost is too small to justify a lasting multiple hit.
• Monitor SaaS names with active repurchase programs and M&A optionality (e.g., CRM, WDAY, DDOG, ZS) over the next 1-3 months for disclosure-risk discounting; avoid buying the buyback narrative blindly during strategic reviews.
• If discovery expands to new defendants or the SEC opens a formal inquiry, cut BX longs rather than adding on weakness; that would be the first signal the issue is becoming a real governance overhang.